Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mym Nutraceuticals Inc (MYM.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 60,217
  • Shares Outstanding, K 113,617
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 36-Month Beta 2.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.03
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings -0.02 on 08/31/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.450 +17.78%
on 12/05/18
0.880 -39.77%
on 11/09/18
-0.280 (-34.57%)
since 11/07/18
3-Month
0.450 +17.78%
on 12/05/18
1.250 -57.60%
on 10/09/18
-0.750 (-58.59%)
since 09/07/18
52-Week
0.450 +17.78%
on 12/05/18
5.000 -89.40%
on 12/22/17
-2.070 (-79.62%)
since 12/07/17

Most Recent Stories

More News
MYM Announces $25,000,000 CDN Equity Investment

MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) ("MYM") is pleased to announce the Company has signed a term sheet for a $25 million equity investment by Alumina Partners LLC, a New York-based private...

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
MYM's Subsidiary, Sublime Culture Inc., Completes Migration to Health Canada's Cannabis Tracking and Licensing System

(via TheNewswire)

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
MYM Poised to Acquire 49% Of Sunmark Growth In Australia and Access to 200 Hectare Farm

(via TheNewswire)

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
MYM Nutraceuticals, New Manufacturing Facility for Cannabis Consumables, CEO Clip Video

Rob Gietl, CEO of MYM Nutraceuticals explains how their cannabis company aims to focus on the medical industry.

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
MYM Appoints Howard Steinberg as Independent Director and Vice-Chairman of the Company

MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (the "Company" or "MYM") is pleased to announce the appointment of Howard Steinberg as independent Director and Vice-Chairman of the Company, effective...

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
MYM Nutraceuticals Establishes At-The-Market Equity Program of Up to $13,400,000

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
MYM Nutraceuticals Establishes At-The-Market Equity Program of up to $13,400,000

(via TheNewswire)

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
MYM Announces Resignation of Ian Ramage From Board of Directors

MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (MYM.CN). (the "Company" or "MYM") announces today that the board of directors received the resignation of Director and General Counsel, Ian Ramage.

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
MYM Announces Resignation of Ian Ramage from Board of Directors

(via TheNewswire)

MYM.CN : 0.530 (+3.92%)
MYMMF : 0.4000 (+7.73%)
Canadian Cannabis Upcoming Legalization Expected to Transform the Legal Marijuana Industry Across North America

PALM BEACH, Florida, September 26, 2018 /PRNewswire/ --

IMLFF : 0.3594 (+13.95%)
CCAN : 0.2353 (-1.96%)
HMMJ.TO : 16.81 (+4.09%)
CHOOF : 0.3393 (+5.27%)
CBWTF : 0.5945 (+2.50%)
MYM.CN : 0.530 (+3.92%)
ALEAF : 1.1757 (+11.37%)
CHOO.CN : 0.465 (+10.71%)
MYMMF : 0.4000 (+7.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.557
1st Resistance Point 0.543
Last Price 0.530
1st Support Level 0.513
2nd Support Level 0.497

See More

52-Week High 5.000
Fibonacci 61.8% 3.262
Fibonacci 50% 2.725
Fibonacci 38.2% 2.188
Last Price 0.530
52-Week Low 0.450

See More

Business Summary

MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. It is focused on medical marijuana business by producing cannabis growing facilities and products. The Cannabidiol brands of the company are HempMed, Joshua Tree, and Dr. Furbaby. The...

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar